| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |